DISHMAN CARBOGEN AMCIS
Back to Income Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,712 Cr | ₹2,616 Cr | ₹2,413 Cr | ₹2,141 Cr | ₹1,912 Cr |
What is the latest Revenue of DISHMAN CARBOGEN AMCIS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,712 Cr |
| Mar2025 | ₹2,616 Cr |
| Mar2024 | ₹2,413 Cr |
| Mar2023 | ₹2,141 Cr |
| Mar2022 | ₹1,912 Cr |
How is Revenue of DISHMAN CARBOGEN AMCIS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,712 Cr | 3.66 | |
| Mar2025 | ₹2,616 Cr | 8.41 | |
| Mar2024 | ₹2,413 Cr | 12.72 | |
| Mar2023 | ₹2,141 Cr | 11.96 | |
| Mar2022 | ₹1,912 Cr | - | |
Compare Revenue of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,718.9 Cr | 7% | 0.1% | -38.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | 7% |
0.1% |
-38.8% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses